Publication | Closed Access

Towards point-of-care diagnosis of Alzheimer’s disease: Multi-analyte based portable chemiresistive platform for simultaneous detection of β-amyloid (1–40) and (1–42) in plasma

Simultaneous DetectionEngineeringNeurochemical BiomarkersBiomedical EngineeringPortable Chemiresistive PlatformAlzheimer's DiseaseBiosensing SystemsBioanalysisNeurologyBioimagingClinical ChemistryBiomarker DiscoveryLaboratory MedicineMolecular ImagingTowards Point-of-care DiagnosisDiagnostic DeviceBiomedicineBiomedical AnalysisBiomedical DiagnosticsBiomarkersInnovative DiagnosticsMedicine